US-based biopharmaceutical company Spinogenix has concluded the enrolment of patients in its Phase II clinical trial of tazbentetol (previously known as SPG302), a synaptic regenerative treatment for ...
UCSF researcher Daniel Mathalon, MD, PhD, believes that burgeoning knowledge about biomarkers — biological measures of a ...
MANCHESTER, UNITED KINGDOM, March 10, 2026 /EINPresswire.com/ -- Monument Therapeutics, a stratified medicine company, ...
A new clinic-ready web-based risk prediction tool called PsyMetRiC is now available to forecast the risk of young people with ...
Denmark: A study published in Diabetes Care has revealed that semaglutide improves insulin sensitivity in patients with schizophrenia who have prediabetes and are overweight or obese. The ...
Add Yahoo as a preferred source to see more of our stories on Google. Dr. Keith Sakata said he has seen 12 patients hospitalized in 2025 after experiencing "AI psychosis." He works in San Francisco ...
Background: Patients suffering from psychotic disorders have an increased risk of comorbid somatic diseases such as cardiovascular disorders and diabetes mellitus. Doctor-related factors, such as ...
Khan, S. and Issa, H. (2026) Uncontrolled Hypothyroidism with Antiphospholipid Syndrome Resulting in Myxedema Psychosis. Open Journal of Psychiatry, 16, 131-138. doi: 10.4236/ojpsych.2026.162010 .
Cambridge Cognition (AIM: COG), the neuroscience technology company whose digital cognitive assessments drive scientific discovery, accelerate drug development and improve patient care, reports that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results